Tenet Healthcare CORP Form 4 insider transactions

Director Christopher S. Lynch reports acquisition of 1,551 restricted stock units in Tenet Healthcare Corp.

Director Cecil D. Haney of Tenet Healthcare Corp. was granted 1,551 restricted stock units on May 23, 2024, which vest on the first anniversary of the grant date.

Director Roy Blunt reports acquisition of 1,551 restricted stock units in Tenet Healthcare Corp.

Director Richard W. Fisher reports acquisition of 1,551 restricted stock units in Tenet Healthcare Corp.

Director Nadja West received 1,551 restricted stock units of Tenet Healthcare Corp on May 23, 2024, which vest on the first anniversary of the grant date.

Director James L. Bierman acquired 1,551 restricted stock units of Tenet Healthcare Corp on May 23, 2024, which vest on the first anniversary of the grant date.

Nadja West, a director at Tenet Healthcare Corp, sold 1,782 shares of common stock at a price of $126.41 on May 9, 2024.

Director Richard W. Fisher sold 2,500 shares of Tenet Healthcare Corp (THC) on May 7, 2024, at a price of $123.2 per share.

Thomas W. Arnst, EVP, Chief Admin. Officer & GC of Tenet Healthcare Corp, sold shares of common stock in multiple transactions on May 1, 2024.

Tenet Healthcare's Chairman and CEO, Saumya Sutaria, reported gifting 125,000 shares of common stock to an irrevocable trust for the benefit of his wife and children on April 5, 2024.

Director Richard J. Mark sold 14,000 shares of Tenet Healthcare Corp (THC) at an average price of $98.98 on March 12, 2024.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp, sold 18,168 shares of common stock at an average price of $96.96 on March 6, 2024.

Saumya Sutaria, Chairman & CEO of Tenet Healthcare, reports the vesting of restricted stock units and subsequent tax withholding.

Lisa Y. Foo, EVP of Commercial Operations at Tenet Healthcare Corp, reports the vesting of restricted stock units and subsequent sale of shares for tax obligations.

R. Scott Ramsey, Principal Accounting Officer of Tenet Healthcare Corp, reports the vesting of restricted stock units and subsequent tax withholding on March 1, 2024.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas Arnst, reports the vesting of restricted stock units and subsequent sale of shares on March 1, 2024.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare, reports the vesting of restricted stock units and subsequent tax withholding.

Lisa Y. Foo, EVP of Commercial Operations at Tenet Healthcare, reports the acquisition of 14,011 restricted stock units on February 28, 2024.

Sun Park, EVP and CFO of Tenet Healthcare, reports the acquisition of 14,011 restricted stock units.

R. Scott Ramsey, Principal Accounting Officer of Tenet Healthcare Corp, reports the acquisition of 2,803 restricted stock units on February 28, 2024.

Saumya Sutaria, Chairman & CEO of Tenet Healthcare Corp, acquired 67,250 restricted stock units on February 28, 2024, which vest in one-third increments annually.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas W. Arnst, reports the acquisition of 16,813 restricted stock units.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp, reports the acquisition of 5,605 restricted stock units.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas Arnst, reports transactions involving common stock and restricted stock units.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare, reports transactions involving common stock and restricted stock units.

R. Scott Ramsey, Principal Accounting Officer of Tenet Healthcare Corp, reports acquisition and disposal of common stock and derivative securities related to restricted stock units.

Saumya Sutaria, Chairman & CEO of Tenet Healthcare Corp, reports acquisition and disposal of common stock and derivative securities related to vesting of restricted stock units.

Lisa Y. Foo, EVP of Commercial Operations at Tenet Healthcare, reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of company stock.